Suchergebnisse - "Favresse, Julien"

PubPharm (26)

1

Asundexian in atrial fibrillation : Can pharmacodynamic data explain the failure?

enthalten in: Thrombosis research | 2024

von Vassart, J. | Didembourg, M. | Morimont, L. | +8

2

Navigating between perpendicular drop and tangent skimming methods for M-protein quantification : a call for clarification of guidelines

enthalten in: Clinical chemistry and laboratory medicine | 2024

von Cabo, J. | Favresse, J.

3

Results of the first survey of the EFLM Task Force Preparation of Labs for Emergencies (TF-PLE)

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Lippi, G. | Cadamuro, J. | Danese, E. | +7

4

Biotin interference in immunoassays : water under the bridge?

enthalten in: Clinical chemistry and laboratory medicine | 2023

von Wauthier, L. | Cabo, J. | Eucher, C. | +3

5

Cellular immunity against SARS-CoV-2 is predominantly boosted in vaccinated individuals with no history of infection

enthalten in: The Journal of infection | 2023

von Favresse, J. | Cabo, J. | Douxfils, J.

CommentOn: J Infect. 2022 May;84(5):e45-e47. - PMID 35278482

6

Assessment of the humoral response in Omicron breakthrough cases in healthcare workers who received the BNT162b2 booster

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Dogné, J. | Douxfils, J.

7

Spike vs. nucleocapsid serum antigens for COVID-19 diagnosis and severity assessment

enthalten in: Clinical chemistry and laboratory medicine | 2022

von Favresse, J. | Bayart, J. | David, C. | +4

8

Nucleocapsid serum antigen determination in SARS-CoV-2 infected patients using the single molecule array technology and prediction of disease severity

enthalten in: The Journal of infection | 2022

von Favresse, J. | Bayart, J. | David, C. | +2

9

Importance of sample dilution in the evaluation of the antibody response after SARS-CoV-2 vaccination

enthalten in: The Journal of infection | 2022

von Favresse, J. | Douxfils, J.

CommentOn: J Infect. 2021 Sep;83(3):381-412. - PMID 34161817

10

Post-SARS-CoV-2 vaccination specific antibody decrease - Thresholds for determining seroprevalence and seroneutralization differ

enthalten in: The Journal of infection | 2021

von Douxfils, J. | Gillot, C. | Mullier, F. | +1

CommentOn: J Infect. 2021 Jul 29;:null. - PMID 34332018